The GSA Welcomes Baxter as the Newest Sponsor of World Sepsis Day
Today, the Global Sepsis Alliance is excited to welcome Baxter as the newest sponsor of World Sepsis Day.
A global leader in acute care and multi-organ support therapies, Baxter is at the forefront of advancing new technologies and revolutionizing treatment for critically ill patients around the world. One advancement is Baxter’s commitment to delivering new therapies in continuous renal replacement therapy (CRRT) and sepsis management options. Today, Baxter offers a set for blood purification able to perform CRRT and remove cytokines and endotoxins at the same time.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital, and surgical products. For more than 85 years, they have been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies, and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
“Patients in the ICU can face serious complications, like sepsis, that lack proven effective treatments – which is why Baxter is committed to furthering innovation in critical care and advancing options for patients in the ICU. We are proud to sponsor World Sepsis Day and be a part of the global discussion around this life-threatening condition.”
We thank Baxter for becoming a sponsor of World Sepsis Day and look forward to working together.